Performance analysis of Evogene (EVGN)
Annual Return
Over the past 3 years, EVGN has had an average annual return of -63.63%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, EVGN has had an average annual return of -55.10%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, EVGN has had an average annual return of -37.78%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Mar 5, 2008, EVGN has had an average annual return of -19.10%, underperforming the benchmark SPY, which returned +11.81% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -50.12% | -41.27% | -77.72% | +19.98% | -57.31% | -65.11% | +209.18% | -23.22% | -35.51% | -39.81% | -36.65% | -12.59% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||
| -53.13% | +109.04% | +14.64% | -26.79% | +49.33% | +171.75% | +2.22% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -8.11% | -13.10% | -12.31% | +1.40% | -9.69% | -37.55% | +24.54% | -50.12% | |||||
| 2025 | -16.16% | -6.88% | -14.42% | -9.50% | -3.58% | +17.33% | -6.33% | +4.28% | -8.64% | +10.40% | -15.85% | +3.56% | -41.27% |
| 2024 | -9.23% | +19.51% | -17.69% | -6.80% | +6.57% | -12.69% | -25.74% | -31.86% | -6.73% | -25.77% | -29.38% | +16.28% | -77.72% |
| 2023 | +14.27% | -4.99% | -17.12% | -6.99% | +2.44% | +78.27% | +0% | -30.81% | -20.79% | -18.32% | +35.74% | +29.19% | +19.98% |
| 2022 | -15.25% | -6.47% | -0% | -18.46% | -10.62% | -18.72% | +6.49% | +26.84% | -20.20% | -12.04% | -14.05% | +11.57% | -57.31% |
| 2021 | +30.22% | -4.09% | -14.14% | -13.49% | -20.18% | -1.72% | -16.37% | +4.89% | -12.00% | -1.14% | -23.76% | -17.58% | -65.11% |
| 2020 | +3.94% | -15.82% | -11.29% | -5.08% | -8.03% | -2.91% | +4.02% | +98.99% | +91.30% | -31.32% | +27.58% | +35.44% | +209.18% |
| 2019 | +16.68% | -6.93% | -14.88% | +12.57% | -25.24% | +4.54% | -9.32% | +10.97% | -2.47% | +1.26% | -15.00% | +11.77% | -23.22% |
| 2018 | +19.23% | +6.28% | -18.25% | -2.52% | -1.29% | -6.53% | +0.70% | -4.87% | +13.51% | -13.51% | -4.46% | -22.96% | -35.51% |
| 2017 | -1.76% | +2.79% | +3.83% | +0.23% | -4.85% | -0.78% | -4.35% | -3.93% | -4.52% | -4.50% | -9.20% | -20.26% | -39.81% |
Drawdown analysis of Evogene (EVGN)
The maximum drawdown for the EVGN was -99.81%, occurring on Jun 26, 2026. This drawdown has not yet recovered.
The current EVGN drawdown is -99.73%.
Since Mar 5, 2008 EVGN has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 4 times
- 20% or more: 5 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.81% | Dec 12, 2013 | 3151 | Jun 26, 2026 | Ongoing | Ongoing | Ongoing |
| -57.54% | Sep 26, 2008 | 43 | Nov 26, 2008 | 263 | Dec 14, 2009 | 306 |
| -39.05% | Apr 12, 2010 | 56 | Jun 30, 2010 | 115 | Dec 13, 2010 | 171 |
| -38.46% | Dec 13, 2010 | 437 | Sep 6, 2012 | 188 | Jun 10, 2013 | 625 |
| -22.22% | Jul 29, 2008 | 17 | Aug 21, 2008 | 5 | Aug 28, 2008 | 22 |
| -10.15% | Jun 11, 2013 | 35 | Jul 31, 2013 | 42 | Sep 30, 2013 | 77 |
| -9.95% | Oct 17, 2013 | 10 | Oct 31, 2013 | 24 | Dec 5, 2013 | 34 |
| -2.53% | Jun 17, 2008 | 4 | Jun 23, 2008 | 25 | Jul 29, 2008 | 29 |
| -2.15% | Dec 5, 2013 | 1 | Dec 6, 2013 | 1 | Dec 9, 2013 | 2 |